There is a growing demand for chronic, wireless neurosensor interface with on-the-fly processing capabilities. Such neurosensor interface is designed with low-power, low-noise operation, thus meeting the urgent clinical needs of providing long-term, neurological health monitoring for patients suffering from conditions such as epilepsy, Alzheimer's disease, and sleep apnea. In collaboration with Boston research groups, we have a wireless recorder designed and validated through bench-top experiments, animal experiments, and scalp EEG recordings.
What we have achieved is an implantable chip capable of recording both regular EEG and high-frequency oscillations, with the following specifications:
Neurotechnologies that allow precise interactions with large-scale neural networks or peripheral nerves are ongoing pursuits of the neural engineering/neuroscience community and industry companies. High density recording is pushed by the BRAIN Initiative, which is to 10,000 times increase the number of neurons simultaneously recorded in the next 15 years. This is towards a better understanding of the brain. Minimally invasive neural interfaces that can selectively address individual axons and fascicles are pushed by healthcare companies and funding agencies, as an alternative approach to treat both mental and physical diseases.
What we have achieved:
Wearable electronics has a 30+ years' history, which shares the vision of interweaving technology into the everyday life. Due to technology advancement and constant human needs for better quality of life, the market of wearable electronics is booming especially in healthcare and life style applications. In 2014, there are 90 million wearables reaching customers including smart watches, wearable 3D motion trackers, sport/activity trackers, smart glasses, smart clothing, and wearable cameras. Along this direction, our group has developed multiple prototypes in collaboration with medical doctors and computer scientists, building tools for disease diagnosis and treatment. Some of our prototypes are in pilot clinical trials with positive feedbacks from both clinicians and patients.
What we are working on: